butyrate enemas will be administered for 12 weeks to children ages 7 to 21 with mild to moderate ulcerative colitis to determine if butyrate therapy can help improve the clinical disease in those children. standard management of the disease will be performed during these 12 weeks including routine laboratory studies and endoscopy.
Age
7–21
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
7-21 years, mild to moderate ulcerative colitis
You may not be if
UC therapy within 4 weeks of study medication initiation
infectious colitis, -pregnancy
Clareo Health | The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
